Dialysis of Drugs 2024 is the essential clinical reference guide for concise, easy-to-use information on the dialyzability of drugs in patients receiving hemodialysis and peritoneal dialysis. Using a simple tabular approach, this resource is available in formats that will suit all users’ needs: mobile apps, pocket-sized booklets, wall charts, and institutional site licenses. These site licenses are particularly suited to larger organizations, such as a group of hospitals or clinics. They permit posting of a pdf format on an institution’s internal library or clinical resource page, allowing access by all clinicians.
The mission of Renal Pharmacy Consultants, provider of Dialysis of Drugs, is to optimize the medication-related outcomes of patients with CKD and related disorders. RPC partners Nancy A Mason, PharmD, and George R Bailie, PharmD, PhD, are clinical pharmacists and academics who have greater than 60 combined years of experience specializing in teaching, research, publication and practice related to the care of dialysis patients.